225 related articles for article (PubMed ID: 35357220)
1. Vaginal Inoculation of Uropathogenic Escherichia coli during Estrus Leads to Genital and Renal Colonization.
Robinson CK; Saenkham-Huntsinger P; Hanson BS; Adams LG; Subashchandrabose S
Infect Immun; 2022 Apr; 90(4):e0053221. PubMed ID: 35357220
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
mBio; 2012; 3(1):. PubMed ID: 22318320
[TBL] [Abstract][Full Text] [Related]
3. Intracellular uropathogenic Escherichia coli are undetectable in urinary bladders after oral mecillinam treatment: An experimental study in a pig model of cystitis.
Stærk K; Grønnemose RB; Palarasah Y; Lund L; Andersen TE
Microb Pathog; 2022 Dec; 173(Pt A):105817. PubMed ID: 36244593
[TBL] [Abstract][Full Text] [Related]
4. Identification and Characterization of a Phase-Variable Element That Regulates the Autotransporter UpaE in Uropathogenic Escherichia coli.
Battaglioli EJ; Goh KGK; Atruktsang TS; Schwartz K; Schembri MA; Welch RA
mBio; 2018 Aug; 9(4):. PubMed ID: 30087170
[TBL] [Abstract][Full Text] [Related]
5. The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities.
Vimont S; Boyd A; Bleibtreu A; Bens M; Goujon JM; Garry L; Clermont O; Denamur E; Arlet G; Vandewalle A
PLoS One; 2012; 7(9):e46547. PubMed ID: 23029548
[TBL] [Abstract][Full Text] [Related]
6. RpoS contributes to phagocyte oxidase-mediated stress resistance during urinary tract infection by Escherichia coli CFT073.
Hryckowian AJ; Welch RA
mBio; 2013 Feb; 4(1):e00023-13. PubMed ID: 23404396
[TBL] [Abstract][Full Text] [Related]
7. Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection.
Forsyth VS; Himpsl SD; Smith SN; Sarkissian CA; Mike LA; Stocki JA; Sintsova A; Alteri CJ; Mobley HLT
mBio; 2020 Apr; 11(2):. PubMed ID: 32345645
[TBL] [Abstract][Full Text] [Related]
8. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
[TBL] [Abstract][Full Text] [Related]
9. Uropathogenic
Li ZP; Li J; Li TL; Song ZY; Gong XZ
Front Cell Infect Microbiol; 2024; 14():1322119. PubMed ID: 38638825
[TBL] [Abstract][Full Text] [Related]
10. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
Habibi M; Asadi Karam MR; Bouzari S
Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
[TBL] [Abstract][Full Text] [Related]
13. Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli.
Kline KA; Schwartz DJ; Gilbert NM; Hultgren SJ; Lewis AL
Infect Immun; 2012 Dec; 80(12):4186-94. PubMed ID: 22988014
[TBL] [Abstract][Full Text] [Related]
14. Bladder infection with uropathogenic
Montalbetti N; Dalghi MG; Bastacky SI; Clayton DR; Ruiz WG; Apodaca G; Carattino MD
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F1-F13. PubMed ID: 34779263
[TBL] [Abstract][Full Text] [Related]
15. Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.
Acharya D; Sullivan MJ; Duell BL; Goh KGK; Katupitiya L; Gosling D; Chamoun MN; Kakkanat A; Chattopadhyay D; Crowley M; Crossman DK; Schembri MA; Ulett GC
mSphere; 2019 Nov; 4(6):. PubMed ID: 31776239
[TBL] [Abstract][Full Text] [Related]
16. Competitive fitness of asymptomatic bacteriuria
George I; Kalairaj MS; Zimmern PE; Ware TH; Subashchandrabose S
Infect Immun; 2024 Jun; 92(6):e0017324. PubMed ID: 38780216
[TBL] [Abstract][Full Text] [Related]
17. Photochemical inactivation as an alternative method to produce a whole-cell vaccine for uropathogenic
Westcott MM; Morse AE; Troy G; Blevins M; Wierzba T; Sanders JW
Microbiol Spectr; 2024 Mar; 12(3):e0366123. PubMed ID: 38315025
[TBL] [Abstract][Full Text] [Related]
18. CpxA Phosphatase Inhibitor Activates CpxRA and Is a Potential Treatment for Uropathogenic Escherichia coli in a Murine Model of Infection.
Fortney KR; Smith SN; van Rensburg JJ; Brothwell JA; Gardner JJ; Katz BP; Ahsan N; Duerfeldt AS; Mobley HLT; Spinola SM
Microbiol Spectr; 2022 Apr; 10(2):e0243021. PubMed ID: 35297652
[TBL] [Abstract][Full Text] [Related]
19.
Stærk K; Grønnemose RB; Nielsen TK; Petersen NA; Palarasah Y; Torres-Puig S; Møller-Jensen J; Kolmos HJ; Lund L; Andersen TE
Microbiology (Reading); 2021 Oct; 167(10):. PubMed ID: 34623231
[TBL] [Abstract][Full Text] [Related]
20. YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration.
Lau ME; Loughman JA; Hunstad DA
Infect Immun; 2012 Dec; 80(12):4123-32. PubMed ID: 22966043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
